197 related articles for article (PubMed ID: 8928075)
1. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
[TBL] [Abstract][Full Text] [Related]
3. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
Movshev BE; Kalinin NN; Petrov MM; Petrova VI
Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
[TBL] [Abstract][Full Text] [Related]
4. [Osmotic activity of plasma in plasmapheresis in patients with multiple myeloma].
Movshev BE; Kalinin NN; Petrov MM; Petrova VI; Zhuravlev VS; Zakharova ES; Khoroshko ND
Ter Arkh; 2001; 73(2):57-60. PubMed ID: 11338858
[TBL] [Abstract][Full Text] [Related]
5. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
Ryzhko VV; Gorodetskiĭ VM
Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
[No Abstract] [Full Text] [Related]
6. Blood volume and hematocrit value in macroglobulinemia and myeloma.
Kopp WL; MacKinney AA; Wasson G
Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
[No Abstract] [Full Text] [Related]
7. [Use of plasmapheresis in surgical hematology].
Abdulkadyrov KM; Shatrov VA; Katsadze IuL
Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic plasmapheresis in immune complex diseases].
Movshev BE; Kalinin NN; Petrova VI
Ter Arkh; 1994; 66(7):70-3. PubMed ID: 7985137
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte aggregation in patients treated by plasma exchange or plasma administration].
Schooneman F; Stoltz JF
Ann Med Interne (Paris); 1994; 145(5):361-4. PubMed ID: 7985950
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
Siami GA; Siami FS
Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
[TBL] [Abstract][Full Text] [Related]
11. [Colloid osmotic pressure and the total protein level in assessing the safety of therapeutic plasmapheresis].
Movshev BE; Semenova GM; Petrova VI; Kalinin NN
Ter Arkh; 1991; 63(7):30-3. PubMed ID: 1788802
[TBL] [Abstract][Full Text] [Related]
12. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
13. Hyperviscosity syndrome in plasma cell dyscrasias.
Mehta J; Singhal S
Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
[TBL] [Abstract][Full Text] [Related]
14. [Rare forms of paraproteinemic hemoblastosis].
Andreeva NE
Ter Arkh; 1984; 56(6):59-63. PubMed ID: 6433500
[TBL] [Abstract][Full Text] [Related]
15. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
Mokeeva RA; Zhuravlev VS
Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
[No Abstract] [Full Text] [Related]
16. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
[TBL] [Abstract][Full Text] [Related]
17. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis and hyperviscosity syndrome].
Corral Alonso M; Barbolla ML
Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
[No Abstract] [Full Text] [Related]
19. [Quantitative assessment of protein replacement in therapeutic plasmapheresis].
Kalinin NN; Movshev BE; Khester D; Petrova VI
Ter Arkh; 2003; 75(2):65-8. PubMed ID: 12685397
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
